Advanced search
Publication Cover
Pharmacogenomics and Personalized Medicine Volume 10, 2017 - Issue
Submit an article Journal homepage
89
Views
2
CrossRef citations to date
0
Altmetric
Review

Hyperbilirubinemia in atazanavir treated HIV-infected patients: the impact of the UGT1A1*28 allele

Periklis Panagopoulos1 2 Department of Internal Medicine, Democritus University of Thrace, Alexandroupoli, Greece
,
Efstathios Maltezos1 2 Department of Internal Medicine, Democritus University of Thrace, Alexandroupoli, Greece
,
Angelos Hatzakis2 Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece
&
Dimitrios Paraskevis2 Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, GreeceCorrespondence[email protected]
Pages 205-208 | Published online: 20 Jun 2017

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Anushka Naidoo, Kogieleum Naidoo, Veron Ramsuran, Millidhashni Reddy & Nesri Padayatchi. (2017) Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele. Pharmacogenomics and Personalized Medicine 10, pages 233-234.
Read now

Articles from other publishers (1)

Laura Saint-Lary, Marc Harris Dassi Tchoupa Revegue, Julie Jesson, Françoise Renaud, Martina Penazzato, Claire L. Townsend, John O'Rourke & Valériane Leroy. (2022) Effectiveness and Safety of Atazanavir Use for the Treatment of Children and Adolescents Living With HIV: A Systematic Review. Frontiers in Pediatrics 10.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.